Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doppelherz is a prominent German consumer healthcare brand owned by Queisser Pharma, specializing in the development and distribution of high-quality dietary supplements and over-the-counter (OTC) medicines. Founded in 1919 with its iconic "Energy Tonic," the brand has evolved into a market leader in Europe, offering a vast portfolio that includes vitamins, minerals, and specialized herbal formulations. The company focuses on key therapeutic areas such as cardiovascular health, immune support, joint care, and ophthalmology. Doppelherz products are characterized by their pharmaceutical-grade quality and are widely available through pharmacies and retail drugstores globally. With a commitment to sustainability and scientific innovation, the brand maintains a significant presence in over 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doppelherz.